These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 37175270)

  • 41. Preparation and characterisation of ecdysterone/hydroxypropyl-Β-cyclodextrin inclusion complex with enhanced oral and transdermal bioavailability.
    Wang L; Li S; Cai H; Liu X; Feng T; Zhao X
    J Microencapsul; 2022 Mar; 39(2):145-155. PubMed ID: 35311602
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Complexation study of the anticancer agent EO-9 with 2-hydroxypropyl-beta-cyclodextrin.
    Beijnen JH; van der Schoot SC; Nuijen B; Flesch FM; Gore A; Mirejovsky D; Lenaz L
    Drug Dev Ind Pharm; 2008 Oct; 34(10):1130-9. PubMed ID: 18663657
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Solubility and release modulation effect of sulfamerazine ternary complexes with cyclodextrins and meglumine.
    Aloisio C; de Oliveira AG; Longhi M
    J Pharm Biomed Anal; 2014 Nov; 100():64-73. PubMed ID: 25129645
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lyophilization monophase solution technique for improvement of the physicochemical properties of an anticancer drug, flutamide.
    Elgindy N; Elkhodairy K; Molokhia A; Elzoghby A
    Eur J Pharm Biopharm; 2010 Feb; 74(2):397-405. PubMed ID: 19944160
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Physicochemical characterization of efavirenz-cyclodextrin inclusion complexes.
    Sathigari S; Chadha G; Lee YH; Wright N; Parsons DL; Rangari VK; Fasina O; Babu RJ
    AAPS PharmSciTech; 2009; 10(1):81-7. PubMed ID: 19148759
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of beta-lapachone and methylated beta-cyclodextrin solid-state systems.
    Cunha-Filho MS; Dacunha-Marinho B; Torres-Labandeira JJ; Martínez-Pacheco R; Landín M
    AAPS PharmSciTech; 2007 Jul; 8(3):E60. PubMed ID: 17915810
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Solubility and Dissolution Enhancement of Dexibuprofen with Hydroxypropylbetacyclodextrin (HPβCD) and Poloxamers (188/407) Inclusion Complexes: Preparation and In Vitro Characterization.
    Munir R; Hadi A; Khan SU; Asghar S; Irfan M; Khan IU; Hameed M; Inam S; Islam N; Hassan SF; Ishtiaq M; Akhtar Shah P; Iqbal MS; Khalid Syed H; Khames A; A S Abourehab M
    Polymers (Basel); 2022 Jan; 14(3):. PubMed ID: 35160569
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Binary and ternary complex formation and characterization of artemisinin with sulfobutyl ether β-cyclodextrin and oleic acid.
    Yousaf Shahzad M; Abbas M; Ansari MT; Abbas M
    Pak J Pharm Sci; 2024 Jan; 37(1):43-52. PubMed ID: 38741399
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced Solubility of Albendazole in Cyclodextrin Inclusion Complex: A Molecular Modeling Approach and Physicochemical Evaluation.
    de Melo CG; da Costa LAG; Rabello MM; de Albuquerque Wanderley Sales V; Ferreira AS; da Silva PCD; Nishimura RHV; da Silva RMF; de Araújo Rolim L; Neto PJR
    Curr Drug Deliv; 2022; 19(1):86-92. PubMed ID: 34126897
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improving the solubility of vorinostat using cyclodextrin inclusion complexes: The physicochemical characteristics, corneal permeability and ocular pharmacokinetics of the drug after topical application.
    Yang J; Ma Y; Luo Q; Liang Z; Lu P; Song F; Zhang Z; Zhou T; Zhang J
    Eur J Pharm Sci; 2022 Jan; 168():106078. PubMed ID: 34838620
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-beta-cyclodextrin.
    Mura P; Faucci MT; Bettinetti GP
    Eur J Pharm Sci; 2001 May; 13(2):187-94. PubMed ID: 11297903
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of hydrophilic polymers on the solubility and dissolution enhancement of rivaroxaban/beta-cyclodextrin inclusion complexes.
    Khan WH; Asghar S; Khan IU; Irfan M; Alshammari A; Riaz Rajoka MS; Munir R; Shah PA; Khalid I; Razzaq FA; Khalid SH
    Heliyon; 2023 Sep; 9(9):e19658. PubMed ID: 37809727
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhancement of apixaban's solubility and dissolution rate by inclusion complex (β-cyclodextrin and hydroxypropyl β-cyclodextrin) and computational calculation of their inclusion complexes.
    Salman ZN; Al-Ani I; Al Azzam KM; Majeed BJM; Abdallah HH; Negim ES
    ADMET DMPK; 2023; 11(4):533-550. PubMed ID: 37937243
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ATR/Raman and fractal characterization of HPBCD/progesterone complex solid particles.
    Fini A; Ospitali F; Zoppetti G; Puppini N
    Pharm Res; 2008 Sep; 25(9):2030-40. PubMed ID: 18597163
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of PVP K30 and/or L-arginine on stability constant of etoricoxib-HPbetaCD inclusion complex: preparation and characterization of etoricoxib-HPbetaCD binary system.
    Shah M; Karekar P; Sancheti P; Vyas V; Pore Y
    Drug Dev Ind Pharm; 2009 Jan; 35(1):118-29. PubMed ID: 18979307
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Solid-state characterization and dissolution properties of naproxen-arginine-hydroxypropyl-beta-cyclodextrin ternary system.
    Mura P; Bettinetti GP; Cirri M; Maestrelli F; Sorrenti M; Catenacci L
    Eur J Pharm Biopharm; 2005 Jan; 59(1):99-106. PubMed ID: 15567306
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preparation and Biophysical Characterization of Quercetin Inclusion Complexes with β-Cyclodextrin Derivatives to be Formulated as Possible Nose-to-Brain Quercetin Delivery Systems.
    Manta K; Papakyriakopoulou P; Chountoulesi M; Diamantis DA; Spaneas D; Vakali V; Naziris N; Chatziathanasiadou MV; Andreadelis I; Moschovou K; Athanasiadou I; Dallas P; Rekkas DM; Demetzos C; Colombo G; Banella S; Javornik U; Plavec J; Mavromoustakos T; Tzakos AG; Valsami G
    Mol Pharm; 2020 Nov; 17(11):4241-4255. PubMed ID: 32986435
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preparation and evaluation of taste masked famotidine formulation using drug/beta-cyclodextrin/polymer ternary complexation approach.
    Patel AR; Vavia PR
    AAPS PharmSciTech; 2008; 9(2):544-50. PubMed ID: 18431648
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multicomponent cyclodextrin system for improvement of solubility and dissolution rate of poorly water soluble drug.
    Patel M; Hirlekar R
    Asian J Pharm Sci; 2019 Jan; 14(1):104-115. PubMed ID: 32104443
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preparation and solid-state characterization of inclusion complexes formed between miconazole and methyl-beta-cyclodextrin.
    Ribeiro A; Figueiras A; Santos D; Veiga F
    AAPS PharmSciTech; 2008; 9(4):1102-9. PubMed ID: 18975116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.